1.	Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia Phase: Phase III Type: Supportive care Status: Active Age: Adult Sponsor: NCI, Other Protocol IDs: CDR0000633817, P30CA012197, CCCWFU-98608, IRB00007690, NCT00855309
2.	Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation Phase: Phase III Type: Supportive care Status: Active Age: 6 months to 21 years Sponsor: NCI, Other Protocol IDs: CDR0000695661, COG-ACCL0934, ACCL0934, NCT01371656
3.	Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Phase: Phase III Type: Supportive care Status: Active Age: 4 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000695718, COG-ACCL1031, ACCL1031, NCT01305200
4.	Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 3 months to 30 years Sponsor: NCI, Other Protocol IDs: ACCL0933, COG-ACCL0933, CDR0000695748, NCT01307579
5.	Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Phase: Phase III Type: Supportive care Status: Active Age: 3 months to 20 years Sponsor: NCI, Other Protocol IDs: ACCL1131, COG-ACCL1131, CDR0000721415, NCT01503515
6.	Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Phase: Phase III Type: Supportive care Status: Approved-not yet active Age: 2 months to 21 years Sponsor: NCI, Other Protocol IDs: ACCL1034, NCI-2013-00595, U10CA095861, COG-ACCL1034, NCT01817075
7.	SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 365 days to 18 years Sponsor: NCI, Other Protocol IDs: 11-001, NCT01574274
8.	Phase I Study of Donor-Derived Cytotoxic T-Cell Lymphocytes to Prevent and Treat Cytomegalovirus or Adenovirus Infection in Patients Who Have Undergone Umbilical Cord Blood Transplantation Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: Any age Sponsor: NCI Protocol IDs: BCM-H-23668, ACT-CAT, H-23668, 8614, NCT01017705
9.	Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: Not specified Sponsor: NCI, Other Protocol IDs: 9L-11-8, NCI-2013-00447, NCT01801046
10.	Ovarian Cancer and Immune Response to Flu Vaccine Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 805443, UPCC 5806 (N01-A1-50024), NCT00478387
11.	Bathing Bundle Regimen in Reducing Gynecological Surgical Site Infection in Patients Undergoing Surgery Phase: No phase specified Type: Supportive care Status: Active Age: 19 and over Sponsor: NCI, Other Protocol IDs: I 189910, NCI-2012-00273, NCT01597804
12.	Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CCCWFU 99212, NCI-2012-00624, NCT01656044
13.	Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy Phase: No phase specified Type: Supportive care Status: Active Age: Over 18 Sponsor: NCI, Other Protocol IDs: 201010722, NCT01695733